miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Reports"
DOI: 10.3892/or.2019.7057
Abstract: Following the publication of this article, the authors have subsequently realized that Fig. 2D (lower middle panel, K562‑control group treated with paclitaxel) contained the same data as the left lower panel (K562 group). The authors have… read more here.
Keywords: regulates multidrug; resistance chronic; panel k562; mir regulates ... See more keywords